Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Detalles Bibliográficos
Autor principal: Jang, Byoung Kuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364356/
https://www.ncbi.nlm.nih.gov/pubmed/32646206
http://dx.doi.org/10.3350/cmh.2020.0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364356/
https://www.ncbi.nlm.nih.gov/pubmed/32646206
http://dx.doi.org/10.3350/cmh.2020.0099

Ejemplares similares